Global Infectious Disease Therapeutics Market

Global Infectious Disease Therapeutics Market Size, Share, Growth Analysis, By Mode of treatment(Vaccines and drugs), By Target organism (Antiviral, antifungal), By Infection type(Parasitic, viral), By Distribution channel(Hospitals, clinics) - Industry Forecast 2024-2031

Report ID: SQMIG35J2030 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 119 | Figures: 77

Global Infectious Disease Therapeutics Market Dynamics

Infectious Disease Therapeutics Market Driver

  • Increased spending to enhance the penetration rate of infectious disease treatments, rising strategies to raise awareness about treatments and diagnosis of these conditions, and increased clinical trial research for the development of new drugs may drive the growth of global infectious disease therapeutics market over the forecast period.

Infectious Disease Therapeutics Market Restraint 

  • Inadequate knowledge about treatments available for disorders, as well as low treatment adoption and reimbursement for certain infectious diseases in developing countries, may limit the growth of the infectious disease therapeutics market over the forecast period.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Infectious Disease Therapeutics Market size was valued at USD 115 billion in 2019 and is poised to grow from USD 119.86 billion in 2023 to USD 166.97 billion by 2031, growing at a CAGR of 4.23% in the forecast period (2024-2031).

Global infectious disease therapeutics market is highly competitive and somewhat fragmented. To maintain a competitive edge, the major industry participants are continually implementing various growth strategies. Innovations, mergers, and acquisitions, collaborations and partnerships are adopted by these players to thrive in the competitive market. In order to provide industries with the most effective and economical solutions, the major market players are also continually concentrating on R&D. 'GlaxoSmithKline plc', 'Merck & Co.', 'Pfizer Inc.', 'Roche Holding AG', 'Novartis AG', 'Sanofi S.A.', 'Johnson & Johnson', 'AstraZeneca plc', 'AbbVie Inc.', 'Amgen Inc.', 'Bristol-Myers Squibb Company', 'Eli Lilly and Company', 'Gilead Sciences, Inc.', 'Bayer AG', 'Novo Nordisk A/S', 'Takeda Pharmaceutical Co. Ltd.', 'Biogen Inc.', 'Boehringer Ingelheim GmbH', 'Allergan plc', 'Celgene Corporation'

Increased spending to enhance the penetration rate of infectious disease treatments, rising strategies to raise awareness about treatments and diagnosis of these conditions, and increased clinical trial research for the development of new drugs may drive the growth of global infectious disease therapeutics market over the forecast period.

Increasing prevalence of malaria disease in developing and underdeveloped countries including India, Africa, and other Southeast Asian countries, as well as increased research and development activities by key manufacturers and health care organisations, are all contributing to market development.

North America held the largest global infectious disease therapeutics market share in 2021 due to the region's growing rate of infectious diseases. This region's large geriatric population has emerged as a significant growth factor for the market during the forecast period. People's increased disposable income has also become an important growth factor. The government's provision of advanced health-care facilities in the form of reimbursement policies has greatly aided market growth. Moreover, the existence of key manufacturers in the United States, as well as an increase in clinical trials for the introduction of new treatment drugs, are estimated to generate to this region's large market share.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Global Cannula System Market
Buy Now GET FREE SAMPLE
Pediatric Clinical Trials Market
Buy Now GET FREE SAMPLE
Global Automated Cell Imaging System Market
Buy Now GET FREE SAMPLE
Immuno Oncology Assays Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Infectious Disease Therapeutics Market

Product ID: SQMIG35J2030

$5,300
BUY NOW GET FREE SAMPLE